Introduction
the inducible expression by astrocytes of ␥-glutamyl transFor the delivery of therapeutic factors to the central nerpeptidase activity, or the constitutive expression of the vous system (CNS), gene transfer using intracerebral multidrug resistance gene product, P-glycoprotein. [14] [15] [16] [17] [18] [19] implantation of engineered cells appears as an attractive The RBE4 cells are not tumorigenic, as inferred from the approach by-passing the blood-brain barrier (BBB) which following observations: (1) they have the same growth strictly limits the exchanges between blood and brain. 1 factor and support requirements as primary cells and do Cells of non-neural origin, such as primary or immornot form colonies in soft agar; (2) like primary cells they talized fibroblasts and myoblasts, when transplanted into form capillary-like structures in tridimensional collagen the CNS, remain often isolated in the brain parenchyma. gels; and (3) they do not produce palpable tumors after More recently, promising results have been reported on subcutaneous injection in irradiated nude mice. 17, 18 When functional integration of neural progenitor cell lines into co-implanted in rat brains with different types of glioma host CNS. [2] [3] [4] These data, together with the observation cells, ␤-galactosidase expressing RBE4 cells (RBEZ cells) that vascular endothelial cells were efficiently used as were shown to survive for up to 5 weeks and to be gene carriers in peripheral organs, [5] [6] [7] [8] [9] [10] [11] [12] prompted us to frequently associated with tumor-infiltrating vascular evaluate the brain endothelial cell as an alternative route profiles. 20 for gene transfer to the CNS. Compared with peripheral Here, we report the long-term survival and integration endothelial cells, cerebral endothelial cells display a capacity of RBE4 and RBEZ cells transplanted into brains unique phenotype characterized by the presence of interof normal adult rats. In addition, RBE4 cells genetically cellular tight junctions and constitute, in association with modified to express murine ␤-nerve growth factor astroglia, the BBB at the interface between blood and (RBE/NGF cells) were evaluated for their ability cerebral parenchyma. 13 to deliver biologically active molecules to responsive In the present study, we describe the use of a rat cerstructures of the CNS. ebral endothelial cell line (RBE4 cells) for gene transfer into the brain of syngeneic adult rats. The RBE4 cells, immortalized by transfection of primary cerebral endo- 
Bisbenzimide-labelled RBE4 and RBEZ cells were grafted in the striatum. The number of brains containing RBEZ cells (lacZ+) was determined after ␤-galactosidase histochemical revelation. Bisbenzimide-labelled RBE/NGF cells were grafted in the striatum and the nucleus basalis, in the right hemisphere. Contralaterally, RBE4 cells were implanted using the same coordinates. Bisbenzimide-labelled cells were observed by UV-light examination (Bisbenzimide+); NGF mRNA was detected by in situ hybridization; biologic effect was assessed by p75 LNGFR immunostaining and stereological quantification. NA, not analyzed. A number of labelled cells were found to migrate out of specific DNA sequence, integrated in RBE4 genome. This sequence could not be amplified from the brain of an agethe graft core (maximal average distance of 0.71 ± 0.15 mm, measured in two representative animals, 1 week matched control animal ( Figure 3) . A dense network of immunoreactive laminin, a major endothelium-derived after graft). Labelled cells were often observed lining host blood vessels, with elongated, crescent-like nuclei (Figure constituent of blood vessel basement membrane, 20, 21 was observed around bisbenzimide-positive cells within the 1b and c).
At 1 year after engraftment, numerous bisbenzimidegraft (Figure 2a and b) , strongly suggesting long-term maintenance of the endothelial phenotype of grafted cells positive cells were still present at the implantation site ( Figure 2 ). These cells did not express the microglial antiin host brain environment. At that time, the integrity of the BBB was preserved, as assessed by the brain-specific gen OX-42 (Figure 2c ) or the astrocytic marker glial fibrillary acidic protein (GFAP) (Figure 2f ), excluding the endothelial glucose transporter type 1 (Glut-1) 22 and endothelial-barrier antigen (EBA) 23 immunoreactivities possibility that staining was due to dead transplanted cells, phagocytozed by glial cells. PCR analysis of the present on the blood vessels within the graft ( Figure  2d , e, g and h). The graft was infiltrated by fibrous-like brain of a RBE4-grafted animal confirmed the presence at that time of the intact neomycin resistance geneastrocytes and astrocytic processes, indicating the 
(g and h) EBA immunoreactivity (g, green fluorescence) on numerous blood vessels within the graft (h, blue fluorescence), indicating that the integrity of the BBB is preserved. (i) Methyl green coloration at the graft site showing a normal cellular density without evidence of tumor formation. Yellow patches are autofluorescent cell debris. Original magnification: (a-c) and (f-h) × 215; (d) and (e) × 540; (i) × 100.
absence of a glial barrier isolating the graft from the host Following engraftment of bisbenzimide-labelled RBEZ cells in the striatum of adult rats, ␤-galactosidase expression brain parenchyma (Figure 2f ).
A total of 11 engrafted rats were killed 1 year after ( Figure 4b ) was detected in all grafted animals (five rats) killed after 2 weeks, whereas transgene expression graduengraftment: two rats grafted with RBE4 cells, two grafted with RBEZ cells and seven grafted with ally declined over longer post-graft periods (3-5 weeks; see Table 1 ). In parallel, bisbenzimide staining was observed in RBE/NGF cells. These animals displayed no apparent behavioral impairment, and histological observation of all grafted animals (a total of 24 animals), up to 1 year after engraftment, indicating that loss of ␤-galactosidase brain sections revealed no evidence of tumor formation ( Figure 2i) . expression was not due to cell death but rather to transgene inactivation. One of the five animals killed 1 week after transplantation (Table 1) was subjected to a quantitative Integration of RBEZ cells into host brain parenchyma and vasculature analysis: from a total of 225 000 ± 19 000 bisbenzimide-labelled cells found in the graft, 12 588 ± 1 174 exhibited ␤-RBE4 cells were infected with a replication-defective retroviral vector driving the nuclear expression of the E. coli ␤-galactosidase activity. These data (taking into account that 75% of RBEZ cells can be detected histochemically in vitro) galactosidase, encoded by the lacZ gene. Using the chromogenic substrate X-gal, about 75% of the ␤-galactosidase reveal that 7.4 ± 0.7% of bisbenzimide-labelled cells expressed ␤-galactosidase. expressing RBEZ cells could be detected in vitro (Figure 4a ). absence of BBB breakdown since no leakage of this molecule was observed at or around the graft site of RBE4 cells (Figure 1b ) or RBEZ cells (not shown). 24 In order further to characterize the precise localization of these transplanted endothelial cells in the host microvasculature, we performed electron microscope analysis 1 week after transplantation of four RBEZ-grafted rat brains. In semi-thin sections, RBEZ cells ␤-galactosidase activity appears as blue perinuclear precipitates (Figure 4e ), which are electron dense at the ultrastructural level. The grafted cells were observed to interact closely with perivascular elements and interestingly, some were found to become part of the host blood vessel endothelium ( Figure  4f and g) with, like host cerebral endothelial cells, no 
DNA sequence in long-term RBE4-grafted rat brain (ethidium bromide
In contrast to cells integrated in host microvasculature, staining immunoreactive laminin was clearly detected, surrounding grafted RBEZ cells within the graft core ( Figure 5b and c), whereas astrocytes were present throughout the Numerous grafted cells were found in close vicinity to graft (Figure 5d ), indicating that transplanted cerebral vascular lumens (Figure 4c ). This location did not appear endothelial cells at 1 week after engraftment, were not to affect the integrity of the BBB, as assessed by EBA isolated from host parenchymal cells as noted above expression in the host vasculature (Figure 4d ). Furthermore, a systemic injection of Evans blue confirmed the 1 year after grafting. Taken together, these observations demonstrate that cerebral endothelial RBEZ cells have the capacity to inte-NGF by RBE/NGF cells could be estimated to 21 ng/10 6 cells per day (Figure 6c ). Under similar conditions, congrate the host brain parenchyma, as well as the microvascular network in a cytoarchitecturally correct manner and trol RBE4 cells supernatant had only a limited effect, likely due to the weak constitutive production by the that brain environment seems to modulate RBEZ cell phenotype.
Figure 4 In vitro characterization and in vivo integration of RBEZ cells. (a) Nuclear localization of ␤-galactosidase activity in RBEZ cells in vitro, after X-gal reaction. (b) In situ localization of grafted RBEZ cells in the striatum 3 weeks after engraftment. (c) High-magnification view of RBEZ cells (arrowheads) suggesting integration within host blood vessel walls. (d) Same section where arrowheads point to the luminal EBA immuno-fluorescence focused on the RBEZ cells shown in (c) (50 m thick section). (e) Light micrograph of a semithin section (2 m thickness) through an 8 day graft where the RBEZ cells present specific blue perinuclear X-gal precipitates. (f and g) Transmission electron micrographs showing the integration of grafted RBEZ cells, either closely apposed to a blood vessel (f) or part of a blood vessel endothelium (g). RBEZ cells are identified by perinuclear electron-dense X-gal precipitates (arrowheads). Original magnification: (a)
endothelial cells of other growth factors, such as basicfibroblast growth factor, known to display a neurotrophic activity (Figure 6c ).
25
NGF secretion capacity and neurotrophic effect of RBE/NGF cells To explore the behavior of NGF-secreting endothelial cells in vivo, stereotactic injections of bisbenzimide-lab-RBE4 cells were infected in vitro with a replication-defective retroviral vector carrying the mouse ␤-NGF gene. To detect NGF transcription in vivo, in situ hybridization experiments were performed on serial horizontal brain ( Figure 6a) ; no signal was detected in control RBE4 parental cells (Figure 6b ). The ability of these clones to sections from RBE/NGF grafted rats. ␤-NGF transcripts were detected in RBE/NGF grafts 3 weeks after transdeliver biologically active ␤-NGF was tested in vitro in rat pheochromocytoma PC12 cells that require the presplantation (Figure 7a ), whereas parental RBE4 grafts were negative (Figure 7b ). ence of ␤-NGF for neuritic outgrowth and neuronal differentiation. A 24-h RBE/NGF cell (clone No. 4) super-
The cholinergic neurons of nb and striatum, which express the low-affinity NGF receptor (p75 LNGFR ), are natant promoted the neurite outgrowth of NGF-primed PC12 cells; the capacity of secretion of biologically active dependent on NGF for their survival and neurite outgrowth. The biological effect of graft-released NGF reflected by axonal sprouting, was assessed by immunostaining of brain sections for p75 LNGFR expression as previously described.
2,26 At 3 weeks after engraftment, p75 LNGFR immunoreactivity, within RBE/NGF grafts ( Figure 7c , e and f), appeared as a dense plexus of stained fibers, likely corresponding to neuronal fibers. No axonal sprouting was observed in the contralateral hemisphere where parental RBE4 cells had been grafted (Figure 7d ). In addition, RBE/NGF grafts placed in the ventral thalamus (n = 4), where no cholinergic neurons are present, failed to evoke any p75 LNGFR immunoreactivity (not shown). These experiments strongly suggest a cholinergic origin of the NGF-promoted sprouts observed in the nb (Figure 7c and e) and the striatal (Figure 7f ) grafts, although immunostaining of some reactive astroglial cells could not be formally excluded. As shown in Figure 8 , significant p75 LNGFR staining, quantified by stereological methods, was detected at 3 weeks (9/10 rats) and 8 weeks (3/10 rats) after engraftment. The biological effect decreased significantly over that period of time, similarly to the evolution of NGF mRNA levels ( Table 1 ). As noticed above for ␤-galactosidase-expressing cells, this decrease was probably due to progressive inactivation of the transgene since the grafted RBE/NGF cells were still present at that time. 27 These results demonstrate the efficacy of RBE/NGF cells in exerting specific neurotrophic and neurotropic effects through in situ delivery of biologically active ␤-NGF protein in the CNS parenchyma.
Discussion
Endothelial cells have been considered as gene vehicles for their capacity to provide secretion of transgene products directly into the blood stream or in the perivascular space of injured vessels. [5] [6] [7] [8] [9] [10] [11] [12] The feasibility of such approaches has been investigated recently using In vitro culture and transfections of RBE4 cells temically were shown to integrate host vessel walls. 6, 8, 9, 11 Growth conditions for RBE4 and RBE4-derived cells were These studies described a cell survival time of up to 5 as described previously. 17 Genetically modified RBEZ weeks. 12 In this article, cerebral microvessel endothelial and RBE/NGF cells were produced by exposure of RBE4 cells were stereotactically transplanted directly into brain cells to the replication-defective retroviral vectors MFGparenchyma. By light and electron microscope analyses, NB 20 and MMuLVisisNGF 2 respectively, containing the we demonstrated the capacity of these cells to integrate E. coli ␤-galactosidase gene with a nuclear localization brain parenchyma as well as its vasculature and to sequence and the gene coding for the murine ␤-NGF, secrete a biologically active growth factor (NGF) into respectively. RBEZ cells were then selected by fluorparenchyma. Long-term survival of grafted cells, at 1 escence-activated cell sorting using the fluorescent ␤-gal year after engraftment, was demonstrated in both substrate, fluorescein di-␤-d-galactopyranoside. 20 Followintegration sites.
dense network of fibers is observed along RBE/NGF grafts (delimited by arrowheads) in the nucleus

Figure 8 Quantification by stereological procedures of p75 LNGFR immunobasalis (nb) at low (c) and high magnification (e), and in the striatum (f). reactivity in RBE/NGF or RBE4 implantation sites, 3 and 8 weeks after (d) No p75 LNGFR -positive fibers are observed in the contralateral nb RBE4 transplantation. RBE/NGF (right hemisphere) and parental RBE4 cells graft (arrowheads). (c-f) were counterstained with methyl green. Original (left hemisphere) were grafted into the striatum and nb in stereotactic magnification: (a and b) × 190 (Nomarski optics); (c)
ing subcloning, RBE/NGF clones were selected by ELISA As soon as 1 week, and up to 1 year after transplanas described. 30 tation, numerous infiltrating astrocytes were detected within the graft core, an indication that transplanted cerIntracerebral grafting procedures Adult male rats (Lewis strain, weighing 270-300 g) were ebral endothelial cells have successfully integrated the host brain parenchyma. In addition, the presence of lamistereotactically grafted (Kopf stereotactic frame), under anesthesia with acepromazine (0.5 mg/kg, i.p.) followed nin surrounding the grafted cells suggests the maintenance of an endothelial phenotype even in a nonvascular by thiopental (50 mg/kg, i.p.) ( Table 1) . Before grafting, RBE4 cells and derived clones (RBEZ position. However, only cells integrated in a cytoarchitectural correct manner, in luminal position, appeared to and RBE/NGF cells) were incubated in culture with bisbenzimide dye (Hoechst 33342; Sigma, St Quentin Falexpress the BBB markers EBA and Glut-1. In contrast, RBEZ cells, co-implanted with glioma cells, did express lavier, France) at a concentration of 7.5 g/ml for 15 min at 37°C. These bisbenzimide-labelled cells do proliferate the Glut-1 marker in both parenchymal and vascular localizations, 20 suggesting differential regulation of the in culture and can be maintained over several passages. Twenty-four animals received, respectively, RBEZ cells endothelial Glut-1 gene expression in tumor-bearing and healthy brains.
(right side) and parental RBE4 cells (left side) into the striatum of both cerebral hemispheres in stereotactic con-RBEZ cells, co-implanted in rats with glioma cells, have been suggested recently, on the basis of light microscope ditions. The coordinates based on the atlas of Paxinos and Watson were: 1.8 posterior; 3.8 lateral; 5 mm ventral. A observations, to integrate preferentially into tumor infiltrating vessels and to proliferate. 20 The apparent lower total of 300 000 cells, suspended in 3 l of grafting solution (phosphate-buffered saline supplemented with level of vascular integration and absence of proliferation of RBEZ cells reported in the present study may reflect 1 mg/ml MgCl 2 and CaCl 2 , and 0.1% glucose), were injected per site over 5 min with a 10 l Exmire syringe the specific proliferative response of transplanted endothelial cells to glioma-derived angiogenic factors and (ITO, Fuji, Japan), and the needle was withdrawn slowly over another 5 min. Following post-graft periods of 1, 2, their preferential tropism for tumor-associated neoformed vessels versus resident vessels in healthy brains.
3, 5, 12 weeks and 1 year, rats were deeply anesthetized with pentobarbital (60 mg/kg, i.p.) and perfused transCompared with fibroblasts, the proliferative and integration capacity of cerebral endothelial cells in brain cardially first with 100 ml of PBS, 0.1 m, pH 7.4, 4°C, followed by 350 ml of 3% paraformaldehyde (PFA) and tumors makes them a powerful tool for the delivery of anticancer active molecules throughout the tumoral mass.
0.1% glutaraldehyde in PBS. Brains were post-fixed, cryoprotected (30% sucrose solution) for 48 h and frozen for Various cell types have been used as vehicles for the delivery of growth factors in animal models of neurodegcryostat sectioning. Indirect immunostaining was performed on alternate free-floating sections, after X-gal reacenerative diseases. 1 Indeed, fibroblasts and myoblasts have been successfully used in Parkinsonian rats. 28, 29 tion, by incubation with specific antibodies, followed by either the avidin-biotin peroxidase (Vector Laboratories, However, their non-neural origin limits their integration, with grafts remaining relatively isolated in brain parenBurlingham, CA, USA) or biotin-fluoresceinated streptavidin (Amersham, Les Ulis, France) procedures. Antichyma. Our results, demonstrating the integration and NGF secretion capacity of cerebral endothelial cells in bodies directed to the following antigens were used: rat EBA (SMI 71; Affinity, Exeter, UK), CD11b (MRC OX-42; brain parenchyma, may justify their use in such animal models. The transplantation of immortalized neural Serotec, Oxford, UK), Glut-1 (Biogenesis, Bournemouth, UK), rat laminin (Sigma), GFAP (Dako, Glostrup, progenitor cells in the brain has also been studied recently.
2-4 Those articles described the absence of Denmark). The specificity of peroxidase and fluorescent immunolabelling was confirmed by the absence of staintumorigenicity of such cell lines and their integration and differentiation capacity in vivo. Immortalized, noning when primary antibodies were omitted. Bisbenzimide-labelled RBE/NGF cells were grafted as tumorigenic cell lines, whether neural progenitors or cerebral endothelial cells, could thus provide unlimited detailed above. In this group of rats (n = 37) a multiple site injection procedure was carried out along a vertical and reproducible biological material for gene transfer in the CNS. axis (2 mm high column), from the nucleus basalis to the dorsal striatum. The coordinates were: 1.8 posterior; 3.8 In conclusion, the RBE4 cell line appears as a versatile and efficient tool for the study of brain endothelial cell lateral; 5 and 7 mm ventral for the striatal and nucleus basalis implantation sites, respectively. Following postbiology or as a therapeutic vector in experimental CNS disorders.
operative periods of 1, 3, 8 weeks and 1 year, rats were deeply anesthetized, perfused with 100 ml of PBS fol-(2 mm) for the EM processing. After post-fixation in the same fixative, the tissues were sliced into 100 m coronal lowed by 350 ml of 4% PFA in PBS, post-fixed, cryoprotected and frozen. Horizontal or coronal brain sections or horizontal vibratome sections. These tissues were processed as floating sections using X-gal histochemistry. (30 m) were cut on the cryostat and free-floating sections were incubated for 36 h under agitation at 4°C with Appropriate tissue slices were selected for EM using standard techniques, with en bloc staining by uranyl acetthe mouse mAb anti-rat p75 low NGF receptor (clone 192; Boehringer, Meylan, France). 31 After rinsing, sections ate and embedding in epon. The preparations were not systematically reacted with lead citrate before the EM were incubated with a biotinylated sheep Ab to mouse Ig (Amersham) and an avidin-biotin-peroxidase complex examination. (Vector). Sections were revealed with a solution of 0.03% diaminobenzidine tetrahydrochloride with nickel chlorIn situ hybridization These experiments were performed as described preide and hydrogen peroxide in Tris buffer saline (0.05 m, pH 7.3) and counterstained with methyl green. In these viously 35 with an antisense digoxigenin-labelled 48-mer oligonucleotide probe complementary to the murine ␤-labelling conditions, we observed either a very faint or no staining of the cerebral blood vessels.
NGF cDNA 36 at the position 897-944 (probe synthesized by R&D Systems Europe, Oxon, UK). Control experiAll animal procedures were in strict accordance with NIH guidelines and French ethics committee. ments, either with RNase A pretreatment of the sections or with the addition of an excess of unlabelled probe during hybridization, abolished all specific ␤-NGF mRNA Stereological quantification of NGF biological effect in vivo signal. Quantification of biological effects induced by RBE/NGF (right hemisphere) and RBE4 (left hemisphere) cells after ␤-NGF bioassay in vitro RBE/NGF cells were plated to a density of 10 4 cells per grafting in the striatum and nucleus basalis was performed by stereological procedures as described by Gundcm 2 in 100 mm dishes and grown for 3-4 days, until confluence (10 7 cells per dish). The medium was changed (10 ersen et al. 32 Briefly, a point counting grid was placed over the video monitor and the areal fraction occupied ml) and NGF-containing supernatants were collected after 24 h. ␤-NGF bioassay was performed as described by the p75 LNGFR immunostaining in grafts was estimated by counting the number of points hitting immunostained by Greene and Rein. 37 profiles, divided by the number of points hitting the section (100 points in our cases), in both transplantation sites
